Prati
Bradley Hintze
Bradley Hintze
Duke University
Potvrđena adresa e-pošte na hintze.org
Naslov
Citirano
Citirano
Godina
Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
D Liebschner, PV Afonine, ML Baker, G Bunkóczi, VB Chen, TI Croll, ...
Acta Crystallographica Section D: Structural Biology 75 (10), 861-877, 2019
21872019
MolProbity: More and better reference data for improved all‐atom structure validation
CJ Williams, JJ Headd, NW Moriarty, MG Prisant, LL Videau, LN Deis, ...
Protein Science 27 (1), 293-315, 2018
16912018
The crystal structure of Mtr4 reveals a novel arch domain required for rRNA processing
RN Jackson, AA Klauer, BJ Hintze, H Robinson, A Van Hoof, SJ Johnson
The EMBO journal 29 (13), 2205-2216, 2010
1252010
Molprobity's ultimate rotamer‐library distributions for model validation
BJ Hintze, SM Lewis, JS Richardson, DC Richardson
Proteins: Structure, Function, and Bioinformatics 84 (9), 1177-1189, 2016
922016
New insights into Hoogsteen base pairs in DNA duplexes from a structure-based survey
H Zhou, BJ Hintze, IJ Kimsey, B Sathyamoorthy, S Yang, JS Richardson, ...
Nucleic acids research 43 (7), 3420-3433, 2015
702015
Model validation: local diagnosis, correction and when to quit
JS Richardson, CJ Williams, BJ Hintze, VB Chen, MG Prisant, LL Videau, ...
Acta Crystallographica Section D: Structural Biology 74 (2), 132-142, 2018
272018
Comparison of annotation services for next-generation sequencing in a large-scale precision oncology program
E Katsoulakis, JE Duffy, B Hintze, NL Spector, MJ Kelley
JCO Precision Oncology 4, 212-221, 2020
152020
Cis-nonPro peptides: Genuine occurrences and their functional roles
CJ Williams, LL Videau, DC Richardson, JS Richardson
bioRxiv, 324517, 2018
142018
Genomic analysis of metastatic solid tumors in veterans: Findings from the VHA National Precision Oncology Program
PJ Poonnen, JE Duffy, B Hintze, M Shukla, TS Brettin, NR Conrad, H Yoo, ...
JCO Precision Oncology 3, 1-13, 2019
132019
CaBLAM: Identification and scoring of disguised secondary structure at low resolution
CJ Williams, BJ Hintze, DC Richardson, JS Richardson
Comp. Cryst. Newslett 4, 33-35, 2013
112013
Mismodeled purines: implicit alternates and hidden Hoogsteens
BJ Hintze, JS Richardson, DC Richardson
Acta Crystallographica Section D: Structural Biology 73 (10), 852-859, 2017
102017
Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer
A Hung, KM Lee, JA Lynch, Y Li, P Poonnen, OV Efimova, BJ Hintze, ...
BMC cancer 21 (1), 1-11, 2021
52021
Implementation of precision oncology in the Veterans Health Administration (VHA).
MJ Kelley, J Duffy, BJ Hintze, CD Williams, NL Spector
Journal of Clinical Oncology 35 (15_suppl), 6507-6507, 2017
52017
Medical oncologists’ perspectives of the veterans affairs national precision oncology program
V Vashistha, PJ Poonnen, JL Snowdon, HG Skinner, V McCaffrey, ...
Plos one 15 (7), e0235861, 2020
32020
ResDe: a new tool for visual definition of distance restraints for crystallographic refinement
BJ Hintze, SJ Johnson
Journal of Applied Crystallography 43 (6), 1540-1542, 2010
32010
Respiratory Syncytial Virus During the COVID-19 Pandemic Compared to Historic Levels: A Retrospective Cohort Study of a Health System
N Movva, M Suh, H Reichert, B Hintze, MP Sendak, Z Wolf, S Carr, ...
The Journal of infectious diseases 226 (Supplement_2), S175-S183, 2022
22022
The Veterans Health Administration Precision Oncology Program for Advanced Prostate Cancer Patients: Expanding tumor NGS opportunities to a broader patient population.
A Sokolova, HH Cheng, BJ Hintze, MJ Kelley, NL Spector, J Duffy, ...
Journal of Clinical Oncology 37 (7_suppl), 193-193, 2019
22019
Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program
V Vashistha, J Armstrong, D Winski, PJ Poonnen, B Hintze, M Price, ...
JCO Oncology Practice 17 (7), e1012-e1020, 2021
12021
EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer
A Hung, KM Lee, PR Alba, Y Li, AZ Gao, BJ Hintze, OV Efimova, ...
Cancer Treatment and Research Communications 27, 100327, 2021
12021
Barriers to prescribing targeted therapies for NSCLC patients with highly actionable gene variants in the VA National Precision Oncology Program.
V Vashistha, J Armstrong, D Winski, M Price, BJ Hintze, P Poonnen, ...
Journal of Clinical Oncology 38 (15_suppl), 2005-2005, 2020
12020
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20